Načítá se...
Should ceftriaxone-resistant Enterobacterales be tested for ESBLs? A PRO/CON debate
ESBLs are a group of plasmid-mediated, diverse, complex and rapidly evolving enzymes that pose a therapeutic challenge today in hospital- and community-acquired infections. Thirty-six years after the first report, diagnostic and therapeutic approaches for ESBLs are still the subject of controversy....
Uloženo v:
| Vydáno v: | JAC Antimicrob Resist |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8210106/ https://ncbi.nlm.nih.gov/pubmed/34223110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jacamr/dlab035 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|